Genstruct is a computational systems biology company that delivers high impact, real time, testable biological insights to enable mechanism-based drug discovery and development for top tier pharmaceutical and biotechnology companies. By developing Causal Network™ models for complex biological systems, Genstruct develops a deep molecular understanding of diseases and drug action, and designs mechanistic biomarkers and molecular diagnostics to facilitate drug development and personalized medicine. Genstruct has validated its technology in partnerships with Pfizer, Berlex/Schering AG, GlaxoSmithKline and others.

Managing Partner Noubar Afeyan is a founder and General Partner Jim Matheson is Chairman of the Board.

www.genstruct.com